Downregulated expression of HSP27 in human low-grade glioma tissues discovered by a quantitative proteomic analysis

Proteome Science

Volumn 8, Issue , 2010, Pages

  Shen, Guobo ^a   Liang, Shufang ^a   Xu, Zhizhong ^a   Zhou, Liangxue ^a   Xiao, Shiyin ^a   Xia, Xiangying ^a   Li, Ronghui ^a   Liao, Ying ^a   You, Chao ^a   Wei, Yuquan ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 27; HEAT SHOCK PROTEIN 90; HEAT SHOCK PROTEIN A5; HEAT SHOCK PROTEIN A9; UNCLASSIFIED DRUG;

ARTICLE; CANCER GRADING; CANCER GROWTH; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GLIOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; ISOTOPE LABELING; MASS SPECTROMETRY; PROTEOMICS; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

EID: 77952298790     PISSN: None     EISSN: 14775956     Source Type: Journal    
DOI: 10.1186/1477-5956-8-17     Document Type: Article

References (35)

1. Concannon CG, Gorman AM, Samali A. On the role of HSP27 in regulating apoptosis. Apoptosis 2003, 8:61-70. 10.1023/A:1021601103096, 12510153.
2. Lichtenfels R, Kellner R, Bukur J, Beck J, Brenner W, Ackermann A, Seliger B. Heat shock protein expression and anti-heat shock protein reactivity in renal cell carcinoma. Proteomics 2002, 2:561-570. 10.1002/1615-9861(200205)2:5<561::AID-PROT561>3.0.CO;2-K, 11987130.
3. Schlesinger MJ. Heat shock proteins. J Biol Chem 1990, 265:12111-12114.
4. Lebret T, Watson RW, Fitzpatrick JM. Heat shock proteins: their role in urological tumors. J Urol 2003, 169:338-46. 10.1016/S0022-5347(05)64123-7, 12478186.
5. Pechan PM. Heat shock proteins and cell proliferation. FEBS Lett 1991, 280:1-4. 10.1016/0014-5793(91)80190-E, 2009952.
6. Fanning NF, Redmond HP. Heat shock proteins in the regulation of the apoptotic response. Sepsis 1998, 2:47-53.
7. Fuqua SA, Oesterreich S, Hilsenbeck SG, Von Hoff DD, Eckardt J, Osborne CK. Heat shock proteins and drug resistance. Breast Cancer Res Treat 1994, 32:67-71. 10.1007/BF00666207, 7819588.
8. Vargas-Roig LM, Gago FE, Tello O, Aznar JC, Ciocca DR. Heat shock protein expression and drug resistance in breast cancer patients treated with induction chemotherapy. Int J Cancer 1998, 79:468-475. 10.1002/(SICI)1097-0215(19981023)79:5<468::AID-IJC4>3.0.CO;2-Z, 9761114.
9. Jakob U, Gaestel M, Engel K, Buchner J. Small heat shock proteins are molecular chaperones. J Biol Chem 1993, 268:1517-1520.
10. Mehlen P, Schulze-Osthoff K, Arrigo AP. Small stress proteins as novel regulators of apoptosis. Heat shock protein 27 blocks Fas/APO-1- and staurosporine-induced cell death. J Biol Chem 1996, 27:16510-16514.
11. Garrido C, Ottavi P, Fromentin A, Hammann A, Arrigo AP, Chauffert B, Mehlen P. HSP27 as a mediator of confluence-dependent resistance to cell death induced by anticancer drugs. Cancer Res 1997, 57:2661-2667.
12. Garrido C, Bruey JM, Fromentin A, Hammann A, Arrigo AP, Solary E. HSP27 inhibits cytochrome c-dependent activation of procaspase-9. FASEB J 1999, 13:2061-2070.
13. Bruey JM, Ducasse C, Bonniaud P, Ravagnan L, Susin SA, Diaz-Latoud C, Gurbuxani S, Arrigo AP, Kroemer G, Solary E, Garrido C. HSP27 negatively regulates cell death by interacting with cytochrome c. Nat Cell Biol 2000, 2:645-652. 10.1038/35023595, 10980706.
14. Mehlen P, Kretz-Remy C, Preville X, Arrigo AP. Human HSP27, drosophila HSP27 and human alphaB-crystallin expression-mediated increase in glutathione is essential for the protective activity of these proteins against TNF alpha-induced cell death. EMBO J 1996, 15:2695-2706. 450205, 8654367.
15. Cardone MH, Roy N, Stennicke HR, Salvesen GS, Franke TF, Stanbridge E, Frisch S, Reed JC. Expression of the heat shock protein HSP27 in human ovarian cancer. Clin Cancer Res 1995, 1:1603-1609.
16. Harrison JD, Jones JA, Ellis IO. Oestrogen receptor D5 antibody is an independent negative prognostic factor in gastric cancer. Br J Surg 1991, 78:334-336. 10.1002/bjs.1800780321, 2021850.
17. King KL, Li AF, Chau GY, Chi CW, Wu CW, Huang CL, Lui WY. Prognostic significance of heat shock protein-27 expression in hepatocellular carcinoma and its relation to histologic grading and survival. Cancer 2000, 88:2464-247. 10.1002/1097-0142(20000601)88:11<2464::AID-CNCR6>3.0.CO;2-W, 10861421.
18. Cornford PA, Dodson AR, Parsons KF, Desmond AD, Woolfenden A, Fordham M, Neoptolemos JP, Ke Y, Foster CS. Heat shock protein expression independently predicts clinical outcome in prostate cancer. Cancer Res 2000, 60:7099-7105.
19. Uozaki H, Horiuchi H, Ishida T, Jijima T, Imamura T, Machinami R. Overexpression of resistance-related proteins (metallothioneins, gluthatione-s -transferase π, heat shock protein 27 and lung-related protein) in osteosarcoma: relationship with poor prognosis. Cancer 1997, 79:2336-2344. 10.1002/(SICI)1097-0142(19970615)79:12<2336::AID-CNCR7>3.0.CO;2-J, 9191521.
20. Ciocca DR, Calderwood SK. Heat shock proteins in cancer: diagnostic, prognostic, predictive, and treatment implications. Cell Stress & Chaperones 2005, 10:86-103. 10.1379/CSC-99r.1, 1176476, 16038406.
21. Khalid H, Tsutsumi K, Yamashita H, Kishikawa M, Yasunaga A, Shibata S. Expression of the small heat shock protein (hsp) 27 in human astrocytomas correlates with histologic grades and tumor growth fractions. Cell Mol Neurobiol 1995, 15(2):257-268. 10.1007/BF02073332, 8590455.
22. Assimakopoulou M, Sotiropoulou-Bonikou G, Maraziotis T, Varakis I. Prognostic significance of HSP-27 in astrocytic brain tumors:an immunohistochemical study. Anticancer Res 1997, 17:2677-2682.
23. Hermisson M, Strik H, Rieger J, Dichgans J, Meyermann R, Weller M. Expression and functional activity of heat shock proteins in human glioblastoma multiforme. Neurology 2000, 54:1357-1364.
24. Bottoni P, Giardina B, Scatena R. Proteomic profiling of heat shock proteins: an emerging molecular approach with direct pathophysiological and clinical implications. Proteomics Clin Appl 2009, 3:636-653.
25. Ong SE, Blagoev B, Kratchmarova I, Kristensen DB, Steen H, Pandey A, Mann M. Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics. Mol Cell Proteomics 2002, 1:376-386. 10.1074/mcp.M200025-MCP200, 12118079.
26. Xu Y, Liang S, Shen G, Xu X, Liu Q, Xu Z, Gong F, Tang M, Wei Y. Application of the SILAC (stable isotope labeling with amino acids in cell culture) technique in quantitative comparisons for tissue proteome expression. Biotechnol Appl Biochem 2009, 54:11-20. 10.1042/BA20090007, 19250064.
27. Liang S, Shen G, Liu Q, Xu Y, Zhou L, Xiao S, Xu Z, Gong F, Wei Y. Isoform-specific expression and characterization of 14-3-3 proteins in human glioma tissues discovered by SILAC-based proteomic analysis. Proteomics Clin Appl 2009, 3:743-753.
28. Liang S, Xu Y, Shen G, Liu Q, Zhao X, Xu Z, Xie X, Gong F, Li R, Wei Y. Quantitative protein expression profiling of 14-3-3 isoforms in human renal carcinoma shows 14-3-3 epsilon is involved in limitedly increasing renal cell proliferation. Electrophoresis 2009, 30(22):4152-4162. 10.1002/elps.200900249, 19960480.
29. Ling B, Liang SF, Xu YH, Zhao XY, Tang MH, Liu XY, Zhao X, Huang CH, Chen LJ, Wei YQ. Differential proteomic profiles of HeLa cells treated with honokiol using a quantitative proteomic strategy. Amino Acids 2008, 35:115-122. 10.1007/s00726-007-0615-z, 18157584.
30. Liang S, Xu X, Lu H, Yang P. Development of deuterated-leucine labeling with immunoprecipitation to analyze cellular protein complex. J Proteomics Bioinformatics 2008, 1:293-301.
31. James CD, He J, Collins VP, Allalunis-Turner MJ, Day RS. Localization of chromosome 9p homozygous deletions in glioma cell lines with markers constituting a continuous linkage group. Cancer Res 1993, 53:3674-3676.
32. Lakka SS, Bhattacharya A, Mohanam S, Boyd D, Rao JS. Regulation of the uPA gene in various grades of human glioma cells. Int J Oncol 2001, 18(1):71-79.
33. Krex D, Mohr B, Hauses M, Ehninger G, Schackert HK, Schackert G. Identification of uncommon chromosomal aberrations in the neuroglioma cell line H4 by spectral karyotyping. J Neuro-Oncology 2001, 52(2):119-128.
34. Akbar MT, Lundberg AM, Liu K, Vidyadaran S, Wells KE, Dolatshad H, Wynn S, Wells DJ, Latchman DS, de Belleroche J. The neuroprotective effects of heat shock protein 27 overexpression in transgenic animals against kainate -induced seizures and hippocampal cell death. J Biol Chem 2003, 278:19956-19965. 10.1074/jbc.M207073200, 12639970.
35. Graner MW, Bigner DD. Chaperone proteins and brain tumors: potential targets and possible therapeutics. Neuro-Oncology 2005, 7:260-277. 10.1215/S1152851704001188, 1871914, 16053701.